Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 11, Number 11—November 2005

Research

Neutralizing Antibody Response and SARS Severity

Mei-Shang Ho*, Wei-Ju Chen*, Hour-Young Chen†, Szu-Fong Lin†, Min-Chin Wang†, Jiali Di†, Yen-Ta Lu‡, Ching-Lung Liu‡, Shan-Chwen Chang§, Chung-Liang Chao¶, Chwan-Chuen King§, Jeng-Min Chiou*, Ih-Jen Su#, and Jyh-Yuan Yang†Comments to Author 
Author affiliations: *Academia Sinica, Taipei, Taiwan; †Center for Disease Control, Taipei, Taiwan; ‡Taipei Mackay Memorial Hospital, Taipei, Taiwan; §National Taiwan University, Taipei, Taiwan; ¶Taipei Hospital, Taipei, Taiwan; #National Health Research Institutes, Taipei, Taiwan

Main Article

Figure 3

Scatterplot of antibody titers of the 247 seropositive study participants (titers of the same participant measured at different times are connected); superimposed is the fitted mean curve (in red) of log2 (antibody titer) between weeks 3 and 13 postinfection based on the linear mixed model by severity (duration of illness) and sex at the median age of 36 years. Each dot represents >1 titer; no distinction is made between single values and those with >1 value.

Figure 3. Scatterplot of antibody titers of the 247 seropositive study participants (titers of the same participant measured at different times are connected); superimposed is the fitted mean curve (in red) of log2 (antibody titer) between weeks 3 and 13 postinfection based on the linear mixed model by severity (duration of illness) and sex at the median age of 36 years. Each dot represents >1 titer; no distinction is made between single values and those with >1 value.

Main Article

TOP